Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: June 2010
-
By Donald Zuhn — Last week, a post on Patently-O presented some interesting results regarding the percent of utility applications that had issued as patents as compared to the total number of issued patents and abandoned applications for eight technology centers (see "USPTO Grant Rate by Technology Center"). The post indicated that the results…
-
By James DeGiulio — After a 15-year effort, the team of Daniel Gibson (at right), Hamilton Smith, and Craig Venter (below left) have created the first cell controlled by a purely synthetic genome. In a press release and accompanying press conference, Dr. Venter described the converted cell as "the first self-replicating species we've had…
-
By Nate Chongsiriwatana — BioNanomatrix, Inc. recently announced the issuance of U.S. Patent No. 7,670,770 for nanochannel arrays that enable high-throughput macromolecular analysis. Previously, single-molecule DNA analysis has been limited by the difficulty of linearizing (untangling) and manipulating intact native DNA. To address these limitations, a Princeton University research team, including Dr. Han Cao,…
Patent Docs 